Adding Pembrolizumab to Olaparib to Treat Pancreatic Cancer in People with an Inherited BRCA Mutation
https://www.facingourrisk.org/research-clinical-trials/study/164/adding-pembrolizumab-to-olaparib-to-treat-pancreatic-cancer-in-people-with-an-inherited-brca-mutation
Clinicaltrials.gov identifier:
NCT04548752 (https://clinicaltrials.gov/show/NCT04548752)
Treatment
Metastatic pancreatic cancer and a BRCA1 or BRCA2 mutation
Study Contact Information:
Principal Investigator: Vincent Chung by email
Southwest Oncology Group
About the Study
This study is researching whether adding the immunotherapy drug Pembrolizumab (Keytruda) to the PARP inhibitor Olaparib (Lynparza) works better than olaparib alone in treating people with metastatic pancreatic cancer who also have an inherited BRCA1 or BRCA2 mutation.
Type of Study
This is a randomized, open label, two-arm study.
- The study is divided into two separate treatment groups: one group will receive olaparib alone, the other group will receive both olaparib and pembrolizumab.
- This is a randomized study, which means that people will not choose which treatment they receive, but will be selected by chance to be one of the treatment groups. Neither patients in the study nor the doctor will get to decide which group participants are placed in.
- The study is open label, which means that once they are placed in a group, participants will know which group they are in and which drugs they will receive.
What the Study Entails:
Both groups:
- Patients in both Group 1 and Group 2 will receive olaparib orally twice per day on days 1-21. Cycles repeat every 21 days as long as the participant doesn't have serious side effects.
- Patients are followed for up to 3 years.
Group 1
- Patients in Group 1 will also receive Pembrolizumab intravenous (IV) over 30 minutes on day 1 of each cycle for up to 18 cycles as long as the.participant doesn't experience serious side effects.
- Beginning with cycle 19, patients will receive Olaparib orally twice per day on days 1-42 and continue with Pembrolizumab IV over 30 minutes on day 1 of each cycle. These cycles repeat every 42 days in the absence of disease progression or unacceptable toxicity.
Study Sites:
There are over 280 (Recruiting) study sites across the U.S. Check out the listing on clinicaltrials.gov or on the Southwest Oncology Group (SWOG) site for specific study sites and contacts.
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- Florida
- Idaho
- Illinois
- Indiana
- Iowa
- Kentucky
- Michigan
- Minnesota
- Missouri
- Montana
- Nebraska
- North Carolina
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Texas
- Washington
- Wisconsin
- Wyoming
Arizona
- Phoenix, Arizona
Cancer Center at Saint Joseph's
Contact: Site Public Contact 602-406-8222
Principal Investigator: Richard L. Deming
Arkansas
- Fort Smith, Arkansas
Mercy Hospital Fort Smith
Contact: Site Public Contact 800-378-9373
Principal Investigator: Jay W. Carlson - Hot Springs, Arkansas
CHI Saint Vincent Cancer Center Hot Springs - Contact: Site Public Contact 308-398-6518 [email protected]
Principal Investigator: Richard L. Deming
California
Mission Hope Medical Oncology - Arroyo Grande
Arroyo Grande, California
Contact: Site Public Contact 916-851-2283 [email protected]
Principal Investigator: Richard L. Deming
Sutter Auburn Faith Hospital
Auburn, California
Contact: Site Public Contact 415-209-2686 [email protected]
Principal Investigator: Ari D. Baron
Sutter Cancer Centers Radiation Oncology Services-Auburn
Auburn, California
Contact: Site Public Contact 415-209-2686 [email protected]
Principal Investigator: Ari D. Baron
Alta Bates Summit Medical Center-Herrick Campus
Berkeley, California
Contact: Site Public Contact 415-209-2686 [email protected]
Principal Investigator: Ari D. Baron
Sutter Cancer Centers Radiation Oncology Services-Cameron Park
Cameron Park, California
Contact: Site Public Contact 415-209-2686 [email protected]
Principal Investigator: Ari D. Baron
Eden Hospital Medical Center
Castro Valley, California
Contact: Site Public Contact 415-209-2686 [email protected]
Principal Investigator: Ari D. Baron
Sutter Davis Hospital
Davis, California
Contact: Site Public Contact 415-209-2686 [email protected]
Principal Investigator: Ari D. Baron
City of Hope Comprehensive Cancer Center
Duarte, California
Contact: Site Public Contact 800-826-4673 [email protected]
Principal Investigator: Vincent Chung
Palo Alto Medical Foundation-Fremont
Fremont, California
Contact: Site Public Contact 415-209-2686 [email protected]
Principal Investigator: Ari D. Baron
Memorial Medical Center
Modesto, California
Contact: Site Public Contact 415-209-2686 [email protected]
Principal Investigator: Ari D. Baron
Palo Alto Medical Foundation-Camino Division
Mountain View, California
Contact: Site Public Contact 415-209-2686 [email protected]
Principal Investigator: Ari D. Baron
Palo Alto Medical Foundation-Gynecologic Oncology
Mountain View, California
Contact: Site Public Contact 415-209-2686 [email protected]
Principal Investigator: Ari D. Baron
Palo Alto Medical Foundation Health Care
Palo Alto, California
Contact: Site Public Contact 415-209-2686 [email protected]
Principal Investigator: Ari D. Baron
Sutter Cancer Centers Radiation Oncology Services-Roseville
Roseville, California
Contact: Site Public Contact 415-209-2686 [email protected]
Principal Investigator: Ari D. Baron
Sutter Roseville Medical Center
Roseville, California
Contact: Site Public Contact 415-209-2686 [email protected]
Principal Investigator: Ari D. Baron
Sutter Medical Center Sacramento
Sacramento, California
Contact: Site Public Contact 415-209-2686 [email protected]
Principal Investigator: Ari D. Baron
California Pacific Medical Center-Pacific Campus
San Francisco, California
Contact: Site Public Contact 415-209-2686 [email protected]
Principal Investigator: Ari D. Baron
Pacific Central Coast Health Center-San Luis Obispo
San Luis Obispo, California
Contact: Site Public Contact [email protected]
Principal Investigator: Richard L. Deming
Mills Health Center
San Mateo, California
Contact: Site Public Contact [email protected]
Principal Investigator: Ari D. Baron
Palo Alto Medical Foundation-Santa Cruz
Santa Cruz, California
Contact: Site Public Contact 415-209-2686 [email protected]
Principal Investigator: Ari D. Baron
Mission Hope Medical Oncology - Santa Maria
Santa Maria, California
Contact: Site Public Contact 916-851-2283 [email protected]
Principal Investigator: Richard L. Deming
Sutter Pacific Medical Foundation
Santa Rosa, California
Contact: Site Public Contact 415-209-2686 [email protected]
Principal Investigator: Ari D. Baron
Palo Alto Medical Foundation-Sunnyvale
Sunnyvale, California
Contact: Site Public Contact 415-209-2686 [email protected]
Principal Investigator: Ari D. Baron
Sutter Cancer Centers Radiation Oncology Services-Vacaville
Vacaville, California
Contact: Site Public Contact 415-209-2686 [email protected]
Principal Investigator: Ari D. Baron
Sutter Solano Medical Center/Cancer Center
Vallejo, California
Contact: Site Public Contact 415-209-2686 [email protected]
Principal Investigator: Ari D. Baron
Colorado
Penrose-Saint Francis Healthcare
Colorado Springs, Colorado
Contact: Site Public Contact 308-398-6518 [email protected]
Principal Investigator: Richard L. Deming
Rocky Mountain Cancer Centers-Penrose
Colorado Springs, Colorado
Contact: Site Public Contact 303-777-2663 [email protected]
Principal Investigator: Richard L. Deming
Porter Adventist Hospital
Denver, Colorado
Contact: Site Public Contact 308-398-6518 [email protected]
Principal Investigator: Richard L. Deming
Mercy Medical Center
Durango, Colorado
Contact: Site Public Contact 308-398-6518 [email protected]
Principal Investigator: Richard L. Deming
Southwest Oncology PC
Durango, Colorado
Contact: Site Public Contact 308-398-6518 [email protected]
Principal Investigator: Richard L. Deming
Saint Anthony Hospital
Lakewood, Colorado
Contact: Site Public Contact 308-398-6518 [email protected]
Principal Investigator: Richard L. Deming
Littleton Adventist Hospital
Littleton, Colorado
Contact: Site Public Contact 308-398-6518 [email protected]
Principal Investigator: Richard L. Deming
Longmont United Hospital
Longmont, Colorado
Contact: Site Public Contact 308-398-6518 [email protected]
Principal Investigator: Richard L. Deming
Rocky Mountain Cancer Centers-Longmont
Longmont, Colorado
Contact: Site Public Contact 303-777-2663 [email protected]
Principal Investigator: Richard L. Deming
Parker Adventist Hospital
Parker, Colorado
Contact: Site Public Contact 308-398-6518 [email protected]
Principal Investigator: Richard L. Deming
Saint Mary Corwin Medical Center
Pueblo, Colorado
Contact: Site Public Contact 308-398-6518 [email protected]
Principal Investigator: Richard L. Deming
Connecticut
Danbury Hospital
Danbury, Connecticut
Contact: Site Public Contact 203-739-8074
Principal Investigator: Wenli Gao
Norwalk Hospital
Norwalk, Connecticut
Contact: Site Public Contact 203-852-2996 [email protected]
Principal Investigator: Richard C. Frank
Florida
Mount Sinai Comprehensive Cancer Center at Aventura
Aventura, Florida
Contact: Site Public Contact 305-674-2625 [email protected]
Principal Investigator: Mike Cusnir
Holy Cross Hospital
Fort Lauderdale, Florida
Contact: Site Public Contact 954-267-7750
Principal Investigator: Philip J. Stella
Mount Sinai Medical Center
Miami Beach, Florida
Contact: Site Public Contact 305-674-2625 [email protected]
Principal Investigator: Mike Cusnir
Idaho
Saint Alphonsus Cancer Care Center-Boise
Boise, Idaho
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: John M. Schallenkamp
Saint Alphonsus Cancer Care Center-Caldwell
Caldwell, Idaho
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: John M. Schallenkamp
Kootenai Medical Center
Coeur d'Alene, Idaho
Contact: Site Public Contact 406-969-6060 [email protected]
Principal Investigator: John M. Schallenkamp
Walter Knox Memorial Hospital
Emmett, Idaho
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: John M. Schallenkamp
Idaho Urologic Institute-Meridian
Meridian, Idaho
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: John M. Schallenkamp
Saint Alphonsus Medical Center-Nampa
Nampa, Idaho
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: John M. Schallenkamp
Kootenai Cancer Center
Post Falls, Idaho
Contact: Site Public Contact 406-969-6060 [email protected]
Principal Investigator: John M. Schallenkamp
Kootenai Cancer Clinic
Sandpoint, Idaho
Contact: Site Public Contact 406-969-6060 [email protected]
Principal Investigator: John M. Schallenkamp
Illinois
Rush - Copley Medical Center
Aurora, Illinois
Contact: Site Public Contact 630-978-6212 [email protected]
Principal Investigator: Suparna Mantha
Illinois CancerCare-Bloomington
Bloomington, Illinois
Contact: Site Public Contact 309-243-3605 [email protected]
Principal Investigator: Bryan A. Faller
Illinois CancerCare-Canton
Canton, Illinois
Contact: Site Public Contact 309-243-3605 [email protected]
Principal Investigator: Bryan A. Faller
Memorial Hospital of Carbondale
Carbondale, Illinois
Contact: Site Public Contact 618-457-5200 [email protected]
Principal Investigator: Bryan A. Faller
SIH Cancer Institute
Carterville, Illinois
Contact: Site Public Contact 618-985-3333 [email protected]
Principal Investigator: Bryan A. Faller
Illinois CancerCare-Carthage
Carthage, Illinois
Contact: Site Public Contact 309-243-3605 [email protected]
Principal Investigator: Bryan A. Faller
Centralia Oncology Clinic
Centralia, Illinois
Contact: Site Public Contact 217-876-4740 [email protected]
Principal Investigator: Bryan A. Faller
Northwestern University
Chicago, Illinois
Contact: Site Public Contact 312-695-1301 [email protected]
Principal Investigator: Aparna Kalyan
Carle on Vermilion
Danville, Illinois
Contact: Site Public Contact 800-446-5532 [email protected]
Principal Investigator: Suparna Mantha
Cancer Care Specialists of Illinois - Decatur
Decatur, Illinois
Contact: Site Public Contact 217-876-4740 [email protected]
Principal Investigator: Bryan A. Faller
Decatur Memorial Hospital
Decatur, Illinois
Contact: Site Public Contact 217-876-4740 [email protected]
Principal Investigator: Bryan A. Faller
Illinois CancerCare-Dixon
Dixon, Illinois
Contact: Site Public Contact 815-285-7800
Principal Investigator: Bryan A. Faller
Carle Physician Group-Effingham
Effingham, Illinois
Contact: Site Public Contact 800-446-5532 [email protected]
Principal Investigator: Suparna Mantha
Crossroads Cancer Center
Effingham, Illinois
Contact: Site Public Contact 217-876-4740 [email protected]
Principal Investigator: Bryan A. Faller
Illinois CancerCare-Galesburg
Galesburg, Illinois
Contact: Site Public Contact 309-243-3605 [email protected]
Principal Investigator: Bryan A. Faller
Western Illinois Cancer Treatment Center
Galesburg, Illinois
Contact: Site Public Contact 309-344-2831
Principal Investigator: Bryan A. Faller
Illinois CancerCare-Kewanee Clinic
Kewanee, Illinois
Contact: Site Public Contact 309-243-3605 [email protected]
Principal Investigator: Bryan A. Faller
Northwestern Medicine Lake Forest Hospital
Lake Forest, Illinois
Contact: Site Public Contact [email protected]
Principal Investigator: Aparna Kalyan
Illinois CancerCare-Macomb
Macomb, Illinois
Contact: Site Public Contact 309-243-3605 [email protected]
Principal Investigator: Bryan A. Faller
Carle Physician Group-Mattoon/Charleston
Mattoon, Illinois
Contact: Site Public Contact 800-446-5532 [email protected]
Principal Investigator: Suparna Mantha
Good Samaritan Regional Health Center
Mount Vernon, Illinois
Contact: Site Public Contact 618-242-4600
Principal Investigator: Jay W. Carlson
Cancer Care Center of O'Fallon
O'Fallon, Illinois
Contact: Site Public Contact 217-876-4762 [email protected]
Principal Investigator: Bryan A. Faller
Illinois CancerCare-Ottawa Clinic
Ottawa, Illinois
Contact: Site Public Contact 309-243-3605 [email protected]
Principal Investigator: Bryan A. Faller
Illinois CancerCare-Pekin
Pekin, Illinois
Contact: Site Public Contact 309-243-3605 [email protected]
Principal Investigator: Bryan A. Faller
Illinois CancerCare-Peoria
Peoria, Illinois
Contact: Site Public Contact 309-243-3605 [email protected]
Principal Investigator: Bryan A. Faller
Methodist Medical Center of Illinois
Peoria, Illinois
Contact: Site Public Contact 309-243-3605 [email protected]
Principal Investigator: Bryan A. Faller
Illinois CancerCare-Peru
Peru, Illinois
Contact: Site Public Contact 309-243-3605 [email protected]
Principal Investigator: Bryan A. Faller
Valley Radiation Oncology
Peru, Illinois
Contact: Site Public Contact 815-664-4141
Principal Investigator: Bryan A. Faller
Illinois CancerCare-Princeton
Princeton, Illinois
Contact: Site Public Contact 309-243-3605 [email protected]
Principal Investigator: Bryan A. Faller
Southern Illinois University School of Medicine
Springfield, Illinois
Contact: Site Public Contact 217-545-7929
Principal Investigator: Bryan A. Faller
Springfield Clinic
Springfield, Illinois
Contact: Site Public Contact 800-444-7541
Principal Investigator: Bryan A. Faller
Memorial Medical Center
Springfield, Illinois
Contact: Site Public Contact 217-788-3528
Principal Investigator: Bryan A. Faller
Carle Cancer Center
Urbana, Illinois
Contact: Site Public Contact 800-446-5532 [email protected]
Principal Investigator: Suparna Mantha
The Carle Foundation Hospital
Urbana, Illinois
Contact: Site Public Contact 800-446-5532 [email protected]
Principal Investigator: Suparna Mantha
Rush-Copley Healthcare Center
Yorkville, Illinois
Contact: Site Public Contact 630-978-6212 [email protected]
Principal Investigator: Suparna Mantha
Indiana
Indiana University/Melvin and Bren Simon Cancer Center
Indianapolis, Indiana
Contact: Site Public Contact 317-278-5632 [email protected]
Principal Investigator: Anita Turk
Iowa
Mary Greeley Medical Center
Ames, Iowa
Contact: Site Public Contact 515-956-4132
Principal Investigator: Debra M. Prow
McFarland Clinic PC - Ames
Ames, Iowa
Contact: Site Public Contact 515-239-4734 [email protected]
Principal Investigator: Debra M. Prow
McFarland Clinic PC-Boone
Boone, Iowa
Contact: Site Public Contact 515-956-4132
Principal Investigator: Debra M. Prow
Medical Oncology and Hematology Associates-West Des Moines
Clive, Iowa
Contact: Site Public Contact 308-398-6518 [email protected]
Principal Investigator: Richard L. Deming
Mercy Cancer Center-West Lakes
Clive, Iowa
Contact: Site Public Contact 308-398-6518 [email protected]
Principal Investigator: Richard L. Deming
Alegent Health Mercy Hospital
Council Bluffs, Iowa
Contact: Site Public Contact 308-398-6518 [email protected]
Principal Investigator: Richard L. Deming
Greater Regional Medical Center
Creston, Iowa
Contact: Site Public Contact 308-398-6518 [email protected]
Principal Investigator: Richard L. Deming
Iowa Methodist Medical Center
Des Moines, Iowa
Contact: Site Public Contact 515-241-6727
Principal Investigator: Robert J. Behrens
Medical Oncology and Hematology Associates-Des Moines
Des Moines, Iowa
Contact: Site Public Contact 515-282-2921
Principal Investigator: Robert J. Behrens
Broadlawns Medical Center
Des Moines, Iowa
Contact: Site Public Contact 515-282-2200
Principal Investigator: Robert J. Behrens
Medical Oncology and Hematology Associates-Laurel
Des Moines, Iowa
Contact: Site Public Contact 308-398-6518 [email protected]
Principal Investigator: Richard L. Deming
Mercy Medical Center - Des Moines
Des Moines, Iowa
Contact: Site Public Contact 308-398-6518 [email protected]
Principal Investigator: Richard L. Deming
Iowa Lutheran Hospital
Des Moines, Iowa
Contact: Site Public Contact 515-241-8704
Principal Investigator: Robert J. Behrens
McFarland Clinic PC-Trinity Cancer Center
Fort Dodge, Iowa
Contact: Site Public Contact 515-956-4132
Principal Investigator: Debra M. Prow
Trinity Regional Medical Center
Fort Dodge, Iowa
Contact: Site Public Contact 515-574-8302
Principal Investigator: Robert J. Behrens
McFarland Clinic PC-Jefferson
Jefferson, Iowa
Contact: Site Public Contact 515-956-4132
Principal Investigator: Debra M. Prow
McFarland Clinic PC-Marshalltown
Marshalltown, Iowa
Contact: Site Public Contact 515-956-4132
Principal Investigator: Debra M. Prow
Methodist West Hospital
West Des Moines, Iowa
Contact: Site Public Contact 515-343-1000
Principal Investigator: Robert J. Behrens
Mercy Medical Center-West Lakes
West Des Moines, Iowa
Contact: Site Public Contact 308-398-6518 [email protected]
Principal Investigator: Richard L. Deming
Kentucky
Flaget Memorial Hospital
Bardstown, Kentucky
Contact: Site Public Contact 308-398-6518 [email protected]
Principal Investigator: Richard L. Deming
Commonwealth Cancer Center-Corbin
Corbin, Kentucky
Contact: Site Public Contact 308-398-6518 [email protected]
Principal Investigator: Richard L. Deming
Saint Joseph Radiation Oncology Resource Center
Lexington, Kentucky
Contact: Site Public Contact 308-398-6518 [email protected]
Principal Investigator: Richard L. Deming
Saint Joseph Hospital East
Lexington, Kentucky
Contact: Site Public Contact 308-398-6518 [email protected]
Principal Investigator: Richard L. Deming
Saint Joseph London
London, Kentucky
Contact: Site Public Contact 308-398-6518 [email protected]
Principal Investigator: Richard L. Deming
Jewish Hospital
Louisville, Kentucky
Contact: Site Public Contact 308-398-6518 [email protected]
Principal Investigator: Richard L. Deming
Saints Mary and Elizabeth Hospital
Louisville, Kentucky
Contact: Site Public Contact 308-398-6518 [email protected]
Principal Investigator: Richard L. Deming
Jewish Hospital Medical Center Northeast
Louisville, Kentucky
Contact: Site Public Contact 308-398-6518 [email protected]
Principal Investigator: Richard L. Deming
Jewish Hospital Medical Center South
Shepherdsville, Kentucky
Contact: Site Public Contact 308-398-6518 [email protected]
Principal Investigator: Richard L. Deming
Michigan
Hickman Cancer Center
Adrian, Michigan
Contact: Site Public Contact 517-265-0116
Principal Investigator: Rex B. Mowat
Saint Joseph Mercy Hospital
Ann Arbor, Michigan
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: Philip J. Stella
Bronson Battle Creek
Battle Creek, Michigan
Contact: Site Public Contact 616-391-1230 [email protected]
Principal Investigator: Kathleen J. Yost
IHA Hematology Oncology Consultants-Brighton
Brighton, Michigan
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: Philip J. Stella
Saint Joseph Mercy Brighton
Brighton, Michigan
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: Philip J. Stella
IHA Hematology Oncology Consultants-Canton
Canton, Michigan
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: Philip J. Stella
Saint Joseph Mercy Canton
Canton, Michigan
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: Philip J. Stella
Caro Cancer Center
Caro, Michigan
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: Philip J. Stella
IHA Hematology Oncology Consultants-Chelsea
Chelsea, Michigan
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: Philip J. Stella
Saint Joseph Mercy Chelsea
Chelsea, Michigan
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: Philip J. Stella
Hematology Oncology Consultants-Clarkston
Clarkston, Michigan
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: Philip J. Stella
Newland Medical Associates-Clarkston
Clarkston, Michigan
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: Philip J. Stella
Ascension Saint John Hospital
Detroit, Michigan
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: Philip J. Stella
Great Lakes Cancer Management Specialists-Doctors Park
East China Township, Michigan
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: Philip J. Stella
Genesee Cancer and Blood Disease Treatment Center
Flint, Michigan
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: Philip J. Stella
Genesee Hematology Oncology PC
Flint, Michigan
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: Philip J. Stella
Genesys Hurley Cancer Institute
Flint, Michigan
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: Philip J. Stella
Hurley Medical Center
Flint, Michigan
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: Philip J. Stella
Helen DeVos Children's Hospital at Spectrum Health
Grand Rapids, Michigan
Contact: Site Public Contact 616-391-1230 [email protected]
Principal Investigator: Kathleen J. Yost
Mercy Health Saint Mary's
Grand Rapids, Michigan
Contact: Site Public Contact 616-391-1230 [email protected]
Principal Investigator: Kathleen J. Yost
Spectrum Health at Butterworth Campus
Grand Rapids, Michigan
Contact: Site Public Contact 616-391-1230 [email protected]
Principal Investigator: Kathleen J. Yost
Academic Hematology Oncology Specialists
Grosse Pointe Woods, Michigan
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: Philip J. Stella
Great Lakes Cancer Management Specialists-Van Elslander Cancer Center
Grosse Pointe Woods, Michigan
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: Philip J. Stella
Michigan Breast Specialists-Grosse Pointe Woods
Grosse Pointe Woods, Michigan
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: Philip J. Stella
Bronson Methodist Hospital
Kalamazoo, Michigan
Contact: Site Public Contact 616-391-1230 [email protected]
Principal Investigator: Kathleen J. Yost
West Michigan Cancer Center
Kalamazoo, Michigan
Contact: Site Public Contact 616-391-1230 [email protected]
Principal Investigator: Kathleen J. Yost
Borgess Medical Center
Kalamazoo, Michigan
Contact: Site Public Contact 616-391-1230 [email protected]
Principal Investigator: Kathleen J. Yost
Sparrow Hospital
Lansing, Michigan
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: Philip J. Stella
Hope Cancer Clinic
Livonia, Michigan
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: Philip J. Stella
Saint Mary Mercy Hospital
Livonia, Michigan
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: Philip J. Stella
Great Lakes Cancer Management Specialists-Macomb Medical Campus
Macomb, Michigan
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: Philip J. Stella
Michigan Breast Specialists-Macomb Township
Macomb, Michigan
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: Philip J. Stella
Saint Mary's Oncology/Hematology Associates of Marlette
Marlette, Michigan
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: Philip J. Stella
Toledo Clinic Cancer Centers-Monroe
Monroe, Michigan
Contact: Site Public Contact 800-444-3561
Principal Investigator: Rex B. Mowat
Mercy Health Mercy Campus
Muskegon, Michigan
Contact: Site Public Contact 616-391-1230 [email protected]
Principal Investigator: Kathleen J. Yost
Lakeland Hospital Niles
Niles, Michigan
Contact: Site Public Contact 616-391-1230
Principal Investigator: Kathleen J. Yost
Cancer and Hematology Centers of Western Michigan - Norton Shores
Norton Shores, Michigan
Contact: Site Public Contact 616-391-1230 [email protected]
Principal Investigator: Kathleen J. Yost
Ascension Providence Hospitals - Novi
Novi, Michigan
Contact: Site Public Contact 248-849-5332 [email protected]
Principal Investigator: Susan E. Lyons
21st Century Oncology-Pontiac
Pontiac, Michigan
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: Philip J. Stella
Hope Cancer Center
Pontiac, Michigan
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: Philip J. Stella
Newland Medical Associates-Pontiac
Pontiac, Michigan
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: Philip J. Stella
Saint Joseph Mercy Oakland
Pontiac, Michigan
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: Philip J. Stella
Spectrum Health Reed City Hospital
Reed City, Michigan
Contact: Site Public Contact 616-391-1230 [email protected]
Principal Investigator: Kathleen J. Yost
Ascension Saint Mary's Hospital
Saginaw, Michigan
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: Philip J. Stella
Oncology Hematology Associates of Saginaw Valley PC
Saginaw, Michigan
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: Philip J. Stella
Lakeland Medical Center Saint Joseph
Saint Joseph, Michigan
Contact: Site Public Contact 616-391-1230 [email protected]
Principal Investigator: Kathleen J. Yost
Marie Yeager Cancer Center
Saint Joseph, Michigan
Contact: Site Public Contact 616-391-1230 [email protected]
Principal Investigator: Kathleen J. Yost
Ascension Providence Hospitals - Southfield
Southfield, Michigan
Contact: Site Public Contact 248-849-5332 [email protected]
Principal Investigator: Susan E. Lyons
Bhadresh Nayak MD PC-Sterling Heights
Sterling Heights, Michigan
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: Philip J. Stella
Ascension Saint Joseph Hospital
Tawas City, Michigan
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: Philip J. Stella
Munson Medical Center
Traverse City, Michigan
Contact: Site Public Contact 616-391-1230 [email protected]
Principal Investigator: Kathleen J. Yost
Advanced Breast Care Center PLLC
Warren, Michigan
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: Philip J. Stella
Great Lakes Cancer Management Specialists-Macomb Professional Building
Warren, Michigan
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: Philip J. Stella
Macomb Hematology Oncology PC
Warren, Michigan
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: Philip J. Stella
Michigan Breast Specialists-Warren
Warren, Michigan
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: Philip J. Stella
Saint John Macomb-Oakland Hospital
Warren, Michigan
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: Philip J. Stella
Saint Mary's Oncology/Hematology Associates of West Branch
West Branch, Michigan
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: Philip J. Stella
Metro Health Hospital
Wyoming, Michigan
Contact: Site Public Contact 616-391-1230 [email protected]
Principal Investigator: Kathleen J. Yost
Huron Gastroenterology PC
Ypsilanti, Michigan
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: Philip J. Stella
IHA Hematology Oncology Consultants-Ann Arbor
Ypsilanti, Michigan
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: Philip J. Stella
Minnesota
Fairview Ridges Hospital
Burnsville, Minnesota
Contact: Site Public Contact 952-993-1517 [email protected]
Principal Investigator: David M. King
Minnesota Oncology - Burnsville
Burnsville, Minnesota
Contact: Site Public Contact 952-993-1517 [email protected]
Principal Investigator: David M. King
Cambridge Medical Center
Cambridge, Minnesota
Contact: Site Public Contact 952-993-1517 [email protected]
Principal Investigator: David M. King
Mercy Hospital
Coon Rapids, Minnesota
Contact: Site Public Contact 952-993-1517 [email protected]
Principal Investigator: David M. King
Fairview Southdale Hospital
Edina, Minnesota 55435
Contact: Site Public Contact 952-993-1517 [email protected]
Principal Investigator: David M. King
Unity Hospital
Fridley, Minnesota
Contact: Site Public Contact 952-993-1517 [email protected]
Principal Investigator: David M. King
Fairview Clinics and Surgery Center Maple Grove
Maple Grove, Minnesota
Contact: Site Public Contact 952-993-1517 [email protected]
Principal Investigator: David M. King
Minnesota Oncology Hematology PA-Maplewood
Maplewood, Minnesota
Contact: Site Public Contact 952-993-1517 [email protected]
Principal Investigator: David M. King
Saint John's Hospital - Healtheast
Maplewood, Minnesota
Contact: Site Public Contact 952-993-1517 [email protected]
Principal Investigator: David M. King
Abbott-Northwestern Hospital
Minneapolis, Minnesota
Contact: Site Public Contact 952-993-1517 [email protected]
Principal Investigator: David M. King
Hennepin County Medical Center
Minneapolis, Minnesota
Contact: Site Public Contact 952-993-1517 [email protected]
Principal Investigator: David M. King
Health Partners Inc
Minneapolis, Minnesota
Contact: Site Public Contact 952-993-1517 [email protected]
Principal Investigator: David M. King
Monticello Cancer Center
Monticello, Minnesota
Contact: Site Public Contact 952-993-1517 [email protected]
Principal Investigator: David M. King
New Ulm Medical Center
New Ulm, Minnesota
Contact: Site Public Contact 952-993-1517 [email protected]
Principal Investigator: David M. King
Fairview Northland Medical Center
Princeton, Minnesota
Contact: Site Public Contact 952-993-1517 [email protected]
Principal Investigator: David M. King
North Memorial Medical Health Center
Robbinsdale, Minnesota
Contact: Site Public Contact 952-993-1517 [email protected]
Principal Investigator: David M. King
Park Nicollet Clinic - Saint Louis Park
Saint Louis Park, Minnesota
Contact: Site Public Contact 952-993-1517 [email protected]
Principal Investigator: David M. King
Regions Hospital
Saint Paul, Minnesota
Contact: Site Public Contact 952-993-1517 [email protected]
Principal Investigator: David M. King
United Hospital
Saint Paul, Minnesota
Contact: Site Public Contact 952-993-1517 [email protected]
Principal Investigator: David M. King
Saint Francis Regional Medical Center
Shakopee, Minnesota
Contact: Site Public Contact 952-993-1517 [email protected]
Principal Investigator: David M. King
Lakeview Hospital
Stillwater, Minnesota
Contact: Site Public Contact 952-993-1517 [email protected]
Principal Investigator: David M. King
Ridgeview Medical Center
Waconia, Minnesota
Contact: Site Public Contact 952-993-1517 [email protected]
Principal Investigator: David M. King
Rice Memorial Hospital
Willmar, Minnesota
Contact: Site Public Contact 952-993-1517 [email protected]
Principal Investigator: David M. King
Minnesota Oncology Hematology PA-Woodbury
Woodbury, Minnesota
Contact: Site Public Contact 952-993-1517 [email protected]
Principal Investigator: David M. King
Fairview Lakes Medical Center
Wyoming, Minnesota
Contact: Site Public Contact 952-993-1517 [email protected]
Principal Investigator: David M. King
Missouri
Saint Louis Cancer and Breast Institute-Ballwin
Ballwin, Missouri
Contact: Site Public Contact 314-251-7058
Principal Investigator: Jay W. Carlson
Saint Francis Medical Center
Cape Girardeau, Missouri
Contact: Site Public Contact 573-334-2230 [email protected]
Principal Investigator: Bryan A. Faller
Southeast Cancer Center
Cape Girardeau, Missouri
Contact: Site Public Contact 573-651-5550
Principal Investigator: Bryan A. Faller
Parkland Health Center - Farmington
Farmington, Missouri
Contact: Site Public Contact 314-996-5569
Principal Investigator: Bryan A. Faller
Capital Region Southwest Campus
Jefferson City, Missouri
Contact: Site Public Contact 573-632-4814 [email protected]
Principal Investigator: Bryan A. Faller
Freeman Health System
Joplin, Missouri
Contact: Site Public Contact 417-347-4030 [email protected]
Principal Investigator: Jay W. Carlson
Mercy Hospital Joplin
Joplin, Missouri
Contact: Site Public Contact 417-556-3074 [email protected]
Principal Investigator: Jay W. Carlson
Delbert Day Cancer Institute at PCRMC
Rolla, Missouri
Contact: Site Public Contact 573-458-8776 [email protected]
Principal Investigator: Jay W. Carlson
Mercy Clinic-Rolla-Cancer and Hematology
Rolla, Missouri
Contact: Site Public Contact 573-458-6379
Principal Investigator: Jay W. Carlson
Heartland Regional Medical Center
Saint Joseph, Missouri
Contact: Site Public Contact 816-271-7937 [email protected]
Principal Investigator: Jay W. Carlson
Saint Louis Cancer and Breast Institute-South City
Saint Louis, Missouri
Contact: Site Public Contact 314-353-1870
Principal Investigator: Jay W. Carlson
Mercy Hospital South
Saint Louis, Missouri
Contact: Site Public Contact [email protected]
Principal Investigator: Jay W. Carlson
Missouri Baptist Medical Center
Saint Louis, Missouri
Contact: Site Public Contact 314-996-5569
Principal Investigator: Bryan A. Faller
Mercy Hospital Saint Louis
Saint Louis, Missouri
Contact: Site Public Contact 314-251-7066
Principal Investigator: Jay W. Carlson
Sainte Genevieve County Memorial Hospital
Sainte Genevieve, Missouri
Contact: Site Public Contact 314-996-5569
Principal Investigator: Bryan A. Faller
Mercy Hospital Springfield
Springfield, Missouri
Contact: Site Public Contact 417-269-4520
Principal Investigator: Jay W. Carlson
CoxHealth South Hospital
Springfield, Missouri
Contact: Site Public Contact 417-269-4520
Principal Investigator: Jay W. Carlson
Missouri Baptist Sullivan Hospital
Sullivan, Missouri
Contact: Site Public Contact 314-996-5569
Principal Investigator: Bryan A. Faller
Missouri Baptist Outpatient Center-Sunset Hills
Sunset Hills, Missouri
Contact: Site Public Contact 314-996-5569
Principal Investigator: Bryan A. Faller
Mercy Hospital Washington
Washington, Missouri
Contact: Site Public Contact 636-390-1600
Principal Investigator: Jay W. Carlson
Montana
Community Hospital of Anaconda
Anaconda, Montana
Contact: Site Public Contact 406-969-6060 [email protected]
Principal Investigator: John M. Schallenkamp
Billings Clinic Cancer Center
Billings, Montana
Contact: Site Public Contact 800-996-2663 [email protected]
Principal Investigator: John M. Schallenkamp
Bozeman Deaconess Hospital
Bozeman, Montana
Contact: Site Public Contact 406-969-6060 [email protected]
Principal Investigator: John M. Schallenkamp
Benefis Healthcare- Sletten Cancer Institute
Great Falls, Montana
Contact: Site Public Contact 406-969-6060 [email protected]
Principal Investigator: John M. Schallenkamp
Great Falls Clinic
Great Falls, Montana
Contact: Site Public Contact 406-969-6060 [email protected]
Principal Investigator: John M. Schallenkamp
Kalispell Regional Medical Center
Kalispell, Montana
Contact: Site Public Contact 406-969-6060 [email protected]
Principal Investigator: John M. Schallenkamp
Community Medical Hospital
Missoula, Montana
Contact: Site Public Contact 406-969-6060 [email protected]
Principal Investigator: John M. Schallenkamp
Nebraska
CHI Health Saint Francis
Grand Island, Nebraska
Contact: Site Public Contact 308-398-6518 [email protected]
Principal Investigator: Richard L. Deming
CHI Health Good Samaritan
Kearney, Nebraska
Contact: Site Public Contact 308-398-6518 [email protected]
Principal Investigator: Richard L. Deming
Saint Elizabeth Regional Medical Center
Lincoln, Nebraska
Contact: Site Public Contact 308-398-6518 [email protected]
Principal Investigator: Richard L. Deming
Nebraska Methodist Hospital
Omaha, Nebraska
Contact: Site Public Contact 402-354-5144
Principal Investigator: Timothy Huyck
Alegent Health Immanuel Medical Center
Omaha, Nebraska
Contact: Site Public Contact 308-398-6518 [email protected]
Principal Investigator: Richard L. Deming
Alegent Health Bergan Mercy Medical Center
Omaha, Nebraska
Contact: Site Public Contact 308-398-6518 [email protected]
Principal Investigator: Richard L. Deming
Alegent Health Lakeside Hospital
Omaha, Nebraska
Contact: Site Public Contact 308-398-6518 [email protected]
Principal Investigator: Richard L. Deming
Creighton University Medical Center
Omaha, Nebraska
Contact: Site Public Contact 308-398-6518 [email protected]
Principal Investigator: Richard L. Deming
Midlands Community Hospital
Papillion, Nebraska
Contact: Site Public Contact 308-398-6518 [email protected]
Principal Investigator: Richard L. Deming
North Carolina
Southeastern Medical Oncology Center-Clinton
Clinton, North Carolina
Contact: Site Public Contact 919-587-9084 [email protected]
Principal Investigator: Samer S. Kasbari
Southeastern Medical Oncology Center-Goldsboro
Goldsboro, North Carolina
Contact: Site Public Contact 919-587-9084 [email protected]
Principal Investigator: Samer S. Kasbari
Southeastern Medical Oncology Center-Jacksonville
Jacksonville, North Carolina
Contact: Site Public Contact 910-587-9084 [email protected]
Principal Investigator: Samer S. Kasbari
Vidant Oncology-Kenansville
Kenansville, North Carolina
Contact: Site Public Contact 252-559-2201 [email protected]
Principal Investigator: Misbah U. Qadir
Vidant Oncology-Kinston
Kinston, North Carolina
Contact: Site Public Contact 252-559-2201 [email protected]
Principal Investigator: Misbah U. Qadir
Vidant Oncology-Richlands
Richlands, North Carolina
Contact: Site Public Contact 252-559-2201 [email protected]
Principal Investigator: Misbah U. Qadir
Ohio
Good Samaritan Hospital - Cincinnati
Cincinnati, Ohio
Contact: Site Public Contact 308-398-6518 [email protected]
Principal Investigator: Richard L. Deming
Bethesda North Hospital
Cincinnati, Ohio
Contact: Site Public Contact 308-398-6518 [email protected]
Principal Investigator: Richard L. Deming
TriHealth Cancer Institute-Westside
Cincinnati, Ohio
Contact: Site Public Contact 308-398-6518 [email protected]
Principal Investigator: Richard L. Deming
TriHealth Cancer Institute-Anderson
Cincinnati, Ohio
Contact: Site Public Contact 308-398-6518 [email protected]
Principal Investigator: Richard L. Deming
Mercy Health - Saint Anne Hospital
Toledo, Ohio
Contact: Site Public Contact 614-488-2118 [email protected]
Principal Investigator: Rex B. Mowat
Toledo Clinic Cancer Centers-Toledo
Toledo, Ohio
Contact: Site Public Contact 800-444-3561
Principal Investigator: Rex B. Mowat
Oklahoma
Cancer Centers of Southwest Oklahoma Research
Lawton, Oklahoma
Contact: Site Public Contact 877-231-4440
Principal Investigator: Sagila George
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma
Contact: Site Public Contact 405-271-8777 [email protected]
Principal Investigator: Sagila George
Integris Southwest Medical Center
Oklahoma City, Oklahoma
Contact: Site Public Contact 888-823-5923 [email protected]
Principal Investigator: Sagila George
Mercy Hospital Oklahoma City
Oklahoma City, Oklahoma
Contact: Site Public Contact 405-752-3402
Principal Investigator: Jay W. Carlson
Oregon
Saint Alphonsus Medical Center-Baker City
Baker City, Oregon
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: John M. Schallenkamp
Saint Alphonsus Medical Center-Ontario
Ontario, Oregon
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: John M. Schallenkamp
Pennsylvania
Lehigh Valley Hospital-Cedar Crest
Allentown, Pennsylvania
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: Philip J. Stella
Lehigh Valley Hospital - Muhlenberg
Bethlehem, Pennsylvania
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: Philip J. Stella
Pocono Medical Center
East Stroudsburg, Pennsylvania
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: Philip J. Stella
Saint Vincent Hospital
Erie, Pennsylvania
Contact: Site Public Contact 814-452-5000
Principal Investigator: Dulabh K. Monga
Lehigh Valley Hospital-Hazleton
Hazleton, Pennsylvania
Contact: Site Public Contact 734-712-3671 [email protected]
Principal Investigator: Philip J. Stella
Jefferson Hospital
Jefferson Hills, Pennsylvania
Contact: Site Public Contact 412-359-3043 [email protected]
Principal Investigator: Dulabh K. Monga
Forbes Hospital
Monroeville, Pennsylvania
Contact: Site Public Contact 412-858-7746
Principal Investigator: Dulabh K. Monga
Allegheny General Hospital
Pittsburgh, Pennsylvania
Contact: Site Public Contact 877-284-2000
Principal Investigator: Dulabh K. Monga
West Penn Hospital
Pittsburgh, Pennsylvania
Contact: Site Public Contact 412-578-5000
Principal Investigator: Dulabh K. Monga
Wexford Health and Wellness Pavilion
Wexford, Pennsylvania
Contact: Site Public Contact 412-359-3043 [email protected]
Principal Investigator: Dulabh K. Monga
Texas
Hendrick Medical Center
Abilene, Texas
Contact: Site Public Contact 325-670-6340
Principal Investigator: Mustapha A. Khalife
Saint Joseph Regional Cancer Center
Bryan, Texas
Contact: Site Public Contact 308-398-6518 [email protected]
Principal Investigator: Richard L. Deming
Washington
Harrison HealthPartners Hematology and Oncology-Bremerton
Bremerton, Washington
Contact: Site Public Contact 308-398-6518 [email protected]
Principal Investigator: Richard L. Deming
Harrison Medical Center
Bremerton, Washington
Contact: Site Public Contact 308-398-6518 [email protected]
Principal Investigator: Richard L. Deming
Highline Medical Center-Main Campus
Burien, Washington
Contact: Site Public Contact 308-398-6518 [email protected]
Principal Investigator: Richard L. Deming
Saint Elizabeth Hospital
Enumclaw, Washington
Contact: Site Public Contact 308-398-6518 [email protected]
Principal Investigator: Richard L. Deming
Saint Francis Hospital
Federal Way, Washington
Contact: Site Public Contact 308-398-6518 [email protected]
Principal Investigator: Richard L. Deming
Saint Clare Hospital
Lakewood, Washington
Contact: Site Public Contact 308-398-6518 [email protected]
Principal Investigator: Richard L. Deming
Harrison HealthPartners Hematology and Oncology-Poulsbo
Poulsbo, Washington
Contact: Site Public Contact 308-398-6518 [email protected]
Principal Investigator: Richard L. Deming
Franciscan Research Center-Northwest Medical Plaza
Tacoma, Washington
Contact: Site Public Contact 308-398-6518 [email protected]
Principal Investigator: Richard L. Deming
Northwest Medical Specialties PLLC
Tacoma, Washington
Contact: Site Public Contact 253-306-0532 [email protected]
Principal Investigator: Richard L. Deming
Wisconsin
ProHealth D N Greenwald Center
Mukwonago, Wisconsin
Contact: Site Public Contact [email protected]
Principal Investigator: Timothy R. Wassenaar
Cancer Center of Western Wisconsin
New Richmond, Wisconsin
Contact: Site Public Contact 952-993-1517 [email protected]
Principal Investigator: David M. King
ProHealth Oconomowoc Memorial Hospital
Oconomowoc, Wisconsin
Contact: Site Public Contact 262-928-7878
Principal Investigator: Timothy R. Wassenaar
ProHealth Waukesha Memorial Hospital
Waukesha, Wisconsin
Contact: Site Public Contact 262-928-7632
Principal Investigator: Timothy R. Wassenaar
UW Cancer Center at ProHealth Care
Waukesha, Wisconsin
Contact: Site Public Contact 262-928-5539 [email protected]
Principal Investigator: Timothy R. Wassenaar
Wyoming
Billings Clinic-Cody
Cody, Wyoming
Contact: Site Public Contact 800-996-2663 [email protected]
Principal Investigator: John M. Schallenkamp
Welch Cancer Center
Sheridan, Wyoming
Contact: Site Public Contact 406-969-6060 [email protected]
Principal Investigator: John M. Schallenkamp
This Study is Open To:
Men and women age 18 years or older can participate if they meet the following criteria:
- Have metastatic pancreatic cancer.
- Have a hereditary BRCA1 or BRCA2 mutation.
- Have received first line platinum-based chemotherapy (i.e. fluorouracil, irinotecan, leucovorin and oxaliplatin [FOLFIRINOX], leucovorin calcium, 5-fluorouracil, and oxaliplatin [FOLFOX], or gemcitabine + cisplatin) for at least 16 weeks but no more than 24 weeks.
- Have had a CT scan or MRI showing stable or responding disease on first line platinum-based chemotherapy within 30 days prior to registration.
This Study is Not Open To:
People are not eligible to participate if they:
- have with a known hypersensitivity to olaparib.
- have already received a type of immunotherapy known as an immune checkpoint inhibitor.
- have had prior therapy with PARP inhibitors.
- are pregnant or nursing
About FORCE
FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.